SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 383,708 shares at $5.98 ($2.3M) on 2025-12-01, disclosed to the SEC on 2025-12-03.
Scheduled sale ($2.3M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.98 | 191,854 | $1.1M | 50.0% |
| 2 | $5.98 | 191,854 | $1.1M | 50.0% |
| Total | $5.98 avg | 383,708 | $2.3M | 100% |
| Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |
| VIR | SELL | 2025-10-07 | $5.8M | — | Filing → |